CUSIP: 162818108
What is CUSIP 162818108?
CUSIP 162818108 identifies CMPI - CHECKMATE PHARMACEUTICALS IN - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 162818108:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2022 Q2 | 0 | $0 | -$54,773,000 | 0 | |
| 2022 Q1 | 17,169,970 | $54,773,000 | -$893,286 | $3.19 | 22 |
| 2021 Q4 | 16,127,537 | $46,290,000 | -$459,888 | $2.87 | 23 |
| 2021 Q3 | 16,249,035 | $64,507,000 | -$649,689 | $3.97 | 27 |
| 2021 Q2 | 16,319,465 | $97,262,000 | -$3,780,455 | $5.96 | 31 |
| 2021 Q1 | 16,681,314 | $202,510,000 | +$6,025,428 | $12.14 | 37 |
| 2020 Q4 | 16,172,706 | $235,874,000 | -$1,573,899 | $14.59 | 36 |
| 2020 Q3 | 16,299,933 | $187,358,000 | +$187,358,000 | $11.51 | 37 |